SHZ Healthcare Drug Manufacturers - Specialty & Generic 002107.SZ

Shandong Wohua Pharmaceutical Co., Ltd.

$ 5.88 -0.51 %

Shandong Wohua Pharmaceutical Co., Ltd. is a Chinese enterprise engaged in the development, production, and distribution of a broad array of medicinal products across the country. The company's extensive product portfolio addresses various therapeutic categories. Key offerings include Xinkeshu tablets, Naoxueshu oral solutions, and Tongluo Huayu capsules, which are specifically formulated for cardiovascular and cerebrovascular health. Beyond these, Shandong Wohua also supplies medications for respiratory conditions, drugs targeting the urinary and digestive systems, anti-rheumatic treatments, and sedative agents. Furthermore, it provides specialized pharmaceuticals tailored for women and children. Headquartered in Weifang, China, the company operates as a subsidiary under the ownership of Beijing Zhongzheng Wanrong Investment (Group) Co., Ltd.

CEO: Shengting Li - https://www.wohua.cn

Summary 30-Y Financials Dividend Analyst Key metrics Ownership / Senat
Price objectif

-

Recommandation

-

DCF

$ 4.92

Loading data...

002107.SZ vs S&P500

Loading data...

No data available.

Quick ratio

1.73

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

30.95

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

0.19

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

15.45 %

reflects reasonable profitability, showing good use of equity.

ROIC

15.40 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

5.81

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.00

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

0.21

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

66.83 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
6 indicates moderate financial health
Altman score
9.22 indicates good financial health and low risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
1.46 indicates that the company has sufficient cash to cover its short-term debts
Debt Ratio
0.00 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.